primaquine has been researched along with Nausea in 3 studies
Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There was no impact of either Malarone or primaquine on psychomotor performance, mood, sleepiness, or fatigue." | 5.10 | The impact of Malarone and primaquine on psychomotor performance. ( Cook, T; Gibson, N; Gray, G; Kenny, G; McCarthy, AE; Paul, MA, 2003) |
| " The most common adverse events were nausea, abdominal pain, headache and insomnia, many of which were mild in severity (30%; 60/203) and transient; 19% of subjects (39/203) experienced moderate (with some interference with daily duties requiring no or minimal medical therapy) adverse events." | 2.76 | Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects. ( Baker, J; Ebringer, A; Edstein, MD; Heathcote, G; Shanks, GD; Waller, M, 2011) |
| "Malarial hepatitis is also unusual in P." | 1.36 | [A case of malarial hepatitis by Plasmodium vivax]. ( Park, JM; Sung, YH, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sung, YH | 1 |
| Park, JM | 1 |
| Ebringer, A | 1 |
| Heathcote, G | 1 |
| Baker, J | 1 |
| Waller, M | 1 |
| Shanks, GD | 1 |
| Edstein, MD | 1 |
| Paul, MA | 1 |
| McCarthy, AE | 1 |
| Gibson, N | 1 |
| Kenny, G | 1 |
| Cook, T | 1 |
| Gray, G | 1 |
2 trials available for primaquine and Nausea
| Article | Year |
|---|---|
Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects.
Topics: Abdominal Pain; Adult; Antimalarials; Cyanosis; Drug Administration Schedule; Female; Headache; Huma | 2011 |
The impact of Malarone and primaquine on psychomotor performance.
Topics: Adult; Affect; Antimalarials; Atovaquone; Colic; Cross-Over Studies; Diarrhea; Double-Blind Method; | 2003 |
1 other study available for primaquine and Nausea
| Article | Year |
|---|---|
[A case of malarial hepatitis by Plasmodium vivax].
Topics: Abdomen; Antimalarials; Erythrocytes; Fatigue; Hepatitis; Humans; Malaria, Vivax; Male; Mefloquine; | 2010 |